AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
SACUBITRIL
9 registrations across 2 African markets— 9 active
Markets with SACUBITRIL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SACUBITRIL VALSARTAN 24/26 mg CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Sept 2028 |
| SACUBITRIL VALSARTAN 49/51 mg CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Sept 2028 |
| SACUBITRIL VALSARTAN 97/103 mg CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Sept 2028 |
| UPERIO comprimé / 100 mg | 🇸🇳Senegal | — | active | — |
| UPERIO comprimé / 200 mg | 🇸🇳Senegal | — | active | — |
| UPERIO comprimé / 50 mg | 🇸🇳Senegal | — | active | — |
| UPERIO comprimé / 200 mg | 🇸🇳Senegal | — | active | — |
| UPERIO comprimé / 100 mg | 🇸🇳Senegal | — | active | — |
| UPERIO comprimé / 50 mg | 🇸🇳Senegal | — | active | — |
SACUBITRIL in Africa — Regulatory Overview
SACUBITRIL is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.